Following the recent FDA approval of the Synergy Disc®, Dr. Todd H. Lanman will present the first full results from the U.S. IDE clinical trial at ISASS 2026. As a principal investigator in the study, Dr. Lanman will share data demonstrating improved clinical outcomes, reduced pain, and higher patient satisfaction compared to fusion.
His presentation will provide insight into how motion-preserving cervical disc technology continues to advance and expand treatment options for patients with degenerative disc disease.
